NPI: 1912992215 · MOUNT KISCO, NY 10549 · Psychiatric Hospital Unit · NPI assigned 09/13/2005
Authorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | CUSACK, MICHELE (EXECUTIVE VICE PRESIDENT & CFO) |
| NPI Enumeration Date | 09/13/2005 |
Other providers sharing the same authorized official: CUSACK, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 934 | $13K |
| 2019 | 8,246 | $390K |
| 2020 | 22,008 | $1.04M |
| 2021 | 35,525 | $1.53M |
| 2022 | 36,521 | $1.55M |
| 2023 | 37,434 | $1.69M |
| 2024 | 29,859 | $1.37M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 8,984 | 8,591 | $1.64M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,130 | 5,843 | $1.03M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,413 | 2,315 | $435K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,524 | 1,669 | $394K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,185 | 1,165 | $362K |
| 80053 | Comprehensive metabolic panel | 11,632 | 10,283 | $253K |
| 70450 | Computed tomography, head or brain; without contrast material | 976 | 941 | $247K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,407 | 1,371 | $233K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,546 | 987 | $230K |
| C1889 | Implantable/insertable device, not otherwise classified | 321 | 319 | $205K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,411 | 1,409 | $152K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,003 | 954 | $144K |
| 96361 | Intravenous infusion, hydration; each additional hour | 491 | 472 | $139K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,909 | 1,823 | $121K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 542 | 322 | $119K |
| 59025 | Fetal non-stress test | 452 | 335 | $110K |
| J3490 | Unclassified drugs | 2,840 | 2,271 | $105K |
| 36415 | Collection of venous blood by venipuncture | 16,174 | 13,046 | $84K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,095 | 606 | $83K |
| 76641 | 1,205 | 1,203 | $83K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 475 | 336 | $75K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,373 | 3,108 | $73K |
| J2704 | Injection, propofol, 10 mg | 2,653 | 2,572 | $69K |
| 86885 | 1,428 | 1,327 | $63K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 212 | 206 | $62K |
| 86900 | 1,742 | 1,604 | $59K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,519 | 1,451 | $59K |
| 41899 | Unlisted procedure, dentoalveolar structures | 38 | 38 | $50K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,269 | 1,255 | $47K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,186 | 1,167 | $47K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,457 | 2,359 | $42K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,104 | 764 | $40K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 532 | 502 | $40K |
| 86901 | 1,746 | 1,607 | $36K | |
| G0378 | Hospital observation service, per hour | 368 | 321 | $36K |
| 87631 | 492 | 485 | $32K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 498 | 386 | $29K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,233 | 2,161 | $27K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,404 | 1,402 | $26K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3,845 | 3,719 | $24K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,947 | 1,752 | $24K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,333 | 1,217 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10,787 | 9,438 | $19K |
| 93975 | 38 | 38 | $19K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 12 | 12 | $18K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,056 | 1,889 | $17K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,568 | 3,370 | $15K |
| 0225U | 1,186 | 1,156 | $15K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 97 | 89 | $15K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,518 | 2,163 | $15K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 70 | 69 | $13K |
| 76830 | Ultrasound, transvaginal | 206 | 203 | $13K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 223 | 217 | $12K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 12 | 12 | $12K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,265 | 3,669 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 125 | 124 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | 782 | 752 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,109 | 1,904 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 725 | 629 | $10K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,400 | 2,179 | $9K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 42 | 41 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,205 | 1,144 | $8K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,643 | 3,226 | $8K |
| 85610 | 2,443 | 2,283 | $8K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,489 | 2,173 | $8K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 145 | 108 | $7K |
| 71046 | Radiologic examination, chest; 2 views | 629 | 623 | $7K |
| 83735 | 1,523 | 1,174 | $7K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 706 | 543 | $7K |
| 77065 | Tomosynthesis, mammo | 70 | 67 | $6K |
| 71045 | Radiologic examination, chest; single view | 1,940 | 1,889 | $6K |
| 97161 | 46 | 46 | $6K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,243 | 2,058 | $5K |
| 87486 | 128 | 127 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 15 | 15 | $5K |
| 84100 | 931 | 651 | $5K | |
| 86769 | 267 | 262 | $5K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 113 | 112 | $4K |
| 87468 | 113 | 113 | $4K | |
| 84703 | 3,078 | 2,923 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 357 | 309 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,154 | 2,057 | $3K |
| C1769 | Guide wire | 27 | 26 | $3K |
| 77066 | Tomosynthesis, mammo | 27 | 27 | $3K |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 257 | 256 | $3K |
| 87581 | 128 | 127 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 151 | 135 | $2K |
| 87484 | 113 | 113 | $2K | |
| 88304 | 28 | 28 | $2K | |
| 80061 | Lipid panel | 132 | 130 | $2K |
| 85730 | 1,950 | 1,870 | $2K | |
| 80320 | 442 | 422 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 132 | 131 | $2K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 24 | 24 | $2K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 34 | 26 | $2K |
| 81001 | 3,069 | 2,938 | $1K | |
| 84439 | 95 | 92 | $1K | |
| J7050 | Infusion, normal saline solution, 250 cc | 188 | 149 | $1K |
| 76642 | 50 | 50 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 28 | 27 | $976.45 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 26 | 24 | $951.99 |
| 83036 | Hemoglobin; glycosylated (A1C) | 111 | 109 | $940.35 |
| A9585 | Injection, gadobutrol, 0.1 ml | 52 | 51 | $898.15 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 164 | 150 | $872.55 |
| 83615 | 186 | 153 | $860.22 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 14 | 12 | $844.92 |
| 84484 | 1,606 | 1,262 | $786.65 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 57 | 53 | $744.28 |
| 83690 | 1,681 | 1,600 | $713.30 | |
| 81003 | 1,902 | 1,853 | $628.98 | |
| 86140 | 285 | 256 | $588.60 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 14 | 14 | $519.17 |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | 232 | 210 | $506.34 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 28 | 27 | $486.15 |
| 86780 | 56 | 55 | $469.56 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 259 | 239 | $432.40 |
| 88312 | 13 | 13 | $354.42 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 52 | 49 | $308.55 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 19 | 12 | $251.90 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 94 | 66 | $248.29 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 54 | 48 | $235.68 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 127 | 123 | $192.40 |
| 82962 | 434 | 351 | $184.36 | |
| 86618 | 184 | 180 | $176.58 | |
| 85379 | 232 | 231 | $154.80 | |
| 85652 | 153 | 137 | $143.99 | |
| 87040 | 655 | 515 | $140.71 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 71 | 63 | $135.31 |
| 87070 | 50 | 49 | $115.20 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 18 | 18 | $113.70 |
| 85651 | 25 | 25 | $92.22 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 16 | 16 | $63.20 |
| 87207 | 140 | 106 | $53.64 | |
| 83605 | 29 | 25 | $0.00 | |
| 85027 | 13 | 12 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 18 | 15 | $0.00 |
| 85007 | 13 | 12 | $0.00 | |
| 84145 | 16 | 14 | $0.00 |